SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AB4. A total of 5 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $407,000 | +38.0% | 50,000 | 0.0% | 0.00% | – |
| Q1 2017 | $295,000 | +23.9% | 50,000 | 0.0% | 0.00% | – |
| Q4 2016 | $238,000 | +2.1% | 50,000 | 0.0% | 0.00% | – |
| Q3 2016 | $233,000 | +21.4% | 50,000 | 0.0% | 0.00% | – |
| Q2 2016 | $192,000 | +27.2% | 50,000 | 0.0% | 0.00% | – |
| Q1 2016 | $151,000 | +12.7% | 50,000 | 0.0% | 0.00% | – |
| Q4 2015 | $134,000 | -3.6% | 50,000 | 0.0% | 0.00% | – |
| Q3 2015 | $139,000 | -16.3% | 50,000 | 0.0% | 0.00% | – |
| Q2 2015 | $166,000 | +37.2% | 50,000 | 0.0% | 0.00% | – |
| Q1 2015 | $121,000 | +39.1% | 50,000 | 0.0% | 0.00% | – |
| Q4 2014 | $87,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 25,000 | $203,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 50,000 | $407,000 | 0.00% |